Genomedx Inc.
Records under this name other than patents Genomedx Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 10,865,452 | Systems and methods for expression-based discrimination of distinct clinical disease states in prostate cancer Formerly held In force · USPTO record | In force | USPTO record | |
| US 9,714,452 | Compositions and Methods for Classifying Thyroid Nodule Disease Formerly held In force · High confidence | In force | High confidence | |
| US 10,422,009 | Compositions and methods for classifying thyroid nodule disease Formerly held In force · USPTO record | In force | USPTO record | |
| US 9,206,482 | Systems and Methods for Expression-Based Classification of Thyroid Tissue Formerly held In force · High confidence | In force | High confidence | |
| US 9,617,604 | Systems and Methods for Expression-Based Classification of Thyroid Tissue Formerly held In force · High confidence | In force | High confidence | |
| US 9,074,258 | Compositions and Methods for Classifying Thyroid Nodule Disease Formerly held In force · High confidence | In force | High confidence | |
| US 11,035,005 | Cancer Diagnostics Using Biomarkers Formerly held In force · High confidence | In force | High confidence | |
| US 9,994,907 | Thyroid Cancer Diagnostics Formerly held In force · High confidence | In force | High confidence | |
| US 10,513,737 | Cancer Diagnostics Using Non-Coding Transcripts Formerly held In force · High confidence | In force | High confidence | |
| US 11,078,542 | Genetic Signatures to Predict Prostate Cancer Metastasis and Identify Tumor Aggressiveness Formerly held In force · High confidence | In force | High confidence |